Skip to content

Public FDA record

Z-0773-2023: RSDL (Reactive Skin Decontamination Lotion) Kit, NSN 6505-21-912-5229. Used to remove and/or neutralize

Recall record Z-0773-2023 for Emergent Protective Products USA Inc. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0773-2023
Company in FDA record
Emergent Protective Products USA Inc
FDA classification date
Jan 10, 2023
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class I

Reason stated in the source

Complaints of leaking packets were received.

Source facts

Action
Emergent sent a RECALL NOTIFICAITON LETTER to its consignees by email on 11/24/2022. The notice explained the issue and requested that the consignee immediately hold the product and notify the firm if any product was forwarded to another organization for further distribution. The email response form provided self inspection instructions and to segregate failed packets and store them in a quarantine location to prevent distribution. Further information and materials were provided to return defective product to Emergent. Packets that have passed inspection criteria can be placed back into active inventory A follow up email recall communication was issued on 12/02/2022 as follows: "Reason for this Additional Notification: To provide information for product replacement and return. To provide information on Sub-Recall procedures. There is potential that packets that have passed visual inspection may have a seal that could be compromised under the certain conditions. These packets will be replaced with new product. In the interim period prior to receipt of new product, the packets that have passed your visual inspection can remain in your hold inventory. Instructions: Please follow the following steps: Complete actions as per the initial notification letter provided on 24 NOV 2022. After the completion of the visual inspection, packets that have passed should be placed into hold inventory. Receive replacement product. As soon as available, Emergent will ship new product to replace the entire initial shipment of the batch associated with the recall. Once the new inventory is received, all remaining packets from the recalled batch (Passed and Failed) should be returned to Emergent. Initiate Sub-Recalls to all customers you have distributed product to. Should you have any questions regarding this product recall, please contact: Brent Sadler, Sr. Director, Quality, bsadler@ebsi.com, 204-396-3815"
Initiated
2022-11-24
Root cause
Packaging change control
Terminated
2024-10-07
Distribution
Distribution to US state of VA (distributor), Canada, and Switzerland
Recall number
Z-0773-2023
Recall status
Terminated
CDRH record ID
197507
FDA classified
2023-01-10
Recall event number
91336

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗